Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

被引：7
|
作者：
Dias, Amanda de Fraga [1 ]
Dallemole, Danieli Rosane [2 ]
Bruinsmann, Franciele Aline [2 ]
Lopes Silva, Luiz Fernando [1 ]
Cruz-Lopez, Olga [3 ,4 ]
Conejo-Garcia, Ana [3 ,4 ]
Oliveira Battastini, Ana Maria [1 ]
Maria Campos, Joaquin [3 ,4 ]
Guterres, Silvia Staniscuaski [2 ]
Pohlmann, Adriana Raffin [2 ]
Figueiro, Fabricio [1 ,5 ]
机构：
[1] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil
[3] Fac Farm, Dept Quim Farmaceut & Organ, C Campus Cartuja S-N, Granada, Spain
[4] Inst Invest Biosanitaria Granada Ibs GRANADA, Granada, Spain
[5] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil
来源：
NANOMEDICINE | 2021年 / 16卷 / 23期
关键词：
bozepinib; drug delivery; glioblastoma; intranasal; lipid-core nanocapsules; temozolomide; LIPID-CORE NANOCAPSULES; DRUG-DELIVERY; POLYMERIC NANOPARTICLES; INTRANASAL DELIVERY; EXPERIMENTAL-DESIGN; GROWTH-INHIBITION; IN-VITRO; CHITOSAN; COMBINATION; GLIOMA;
D O I：
10.2217/nnm-2021-0164
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Aim: To develop and characterize bozepinib-loaded lipid-core nanocapsules (BZP-LNC+) as a potential treatment for glioblastoma (GBM). Methods: Characterization of nanocapsules was performed by diameter, polydispersity index, zeta potential, pH and encapsulation efficiency. GBM cell viability, cell cycle and Annexin/PI were evaluated after BZP-LNC+ treatment. Synergism between BZP-LNC+ and temozolomide (TMZ) was performed by CompuSyn software and confirmed in vitro and in vivo. Results: BZP-LNC+ showed adequate particle sizes, positive zeta potential, narrow size distribution and high encapsulation efficiency. BZP-LNC+ reduces GBM growth by inducing apoptosis. BZP-LNC+ and TMZ showed synergistic effect in vitro and reduced the in vivo glioma growth by approximately 81%. Conclusion: The present study provides proof-of-principle insights for the combination of these drugs for GBM treatment.
引用
收藏
页码：2095 / 2115
页数：21
相关论文
共 50 条
  • [31] Nose-to-brain delivery of sumatriptan-loaded nanostructured lipid carriers: preparation, optimization, characterization and pharmacokinetic evaluation
    Masjedi, Moein
    Azadi, Amir
    Heidari, Reza
    Mohammadi-Samani, Soliman
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2020, 72 (10) : 1341 - 1351
  • [32] Nose-to-brain delivery of self-assembled curcumin-nanocochleates for glioblastoma treatment
    Bari, Dipak B.
    Helaskar, Suchita R.
    Gagarani, Manish B.
    Pardeshi, Chandrakantsing, V
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2025, 104
  • [33] Nose-to-brain co-delivery of drugs for glioblastoma treatment using nanostructured system
    Ferreira, Natalia N.
    de Oliveira Junior, Edilson
    Granja, Sara
    Boni, Fernanda, I
    Ferreira, Leonardo M. B.
    Cury, Beatriz S. F.
    Santos, Lilian C. R.
    Reis, Rui M.
    Lima, Eliana M.
    Baltazar, Fatima
    Gremiao, Maria Palmira D.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 603
  • [34] Formulation and Optimization of Aripiprazole-Loaded Nanostructured Lipid Carriers for Nose-to-Brain Delivery
    Albaqshi, Layla
    Singh, Amanjot
    Khan, Shahzad
    Kumar, Manish
    Kour, Jagpreet
    Pottathil, Shinu
    Aldhubiab, Bandar
    Tiwari, Abhishek
    Nair, Anroop B.
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (02) : 579 - 588
  • [35] Nose-to-brain delivery of hesperidin nanoparticles loaded in-situ gel for neuroprotective action
    Bamankar, Suraj
    Londhe, Vaishali
    ANNALES PHARMACEUTIQUES FRANCAISES, 2023, 81 (06): : 985 - 996
  • [36] Nose-to-brain peptide delivery - The potential of nanotechnology
    Samaridou, Eleni
    Alonso, Maria Jose
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (10) : 2888 - 2905
  • [37] SLN approach for nose-to-brain delivery of alprazolam
    Alok Pratap Singh
    Shailendra K. Saraf
    Shubhini A. Saraf
    Drug Delivery and Translational Research, 2012, 2 : 498 - 507
  • [38] Mucoadhesive Amphiphilic Methacrylic Copolymer-Functionalized Poly(ε-caprolactone) Nanocapsules for Nose-to-Brain Delivery of Olanzapine
    Fonseca, Francisco N.
    Betti, Andresa H.
    Carvalho, Flavia C.
    Gremiao, Maria P. D.
    Dimer, Frantiescoli A.
    Guterres, Silvia S.
    Tebaldi, Marli L.
    Rates, Stela M. K.
    Pohlmann, Adriana R.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2015, 11 (08) : 1472 - 1481
  • [39] Phytochemical-loaded mesoporous silica nanoparticles for nose-to-brain olfactory drug delivery
    Lungare, Shital
    Hallam, Keith
    Badhan, Raj K. S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2016, 513 (1-2) : 280 - 293
  • [40] SLN approach for nose-to-brain delivery of alprazolam
    Singh, Alok Pratap
    Saraf, Shailendra K.
    Saraf, Shubhini A.
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2012, 2 (06) : 498 - 507
12345